Teleflex Incorporated (NYSE:TFX – Free Report) – Zacks Research lowered their Q2 2026 EPS estimates for Teleflex in a research note issued on Tuesday, June 24th. Zacks Research analyst R. Department now forecasts that the medical technology company will post earnings per share of $3.91 for the quarter, down from their previous estimate of $3.93. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex’s FY2027 earnings at $15.09 EPS.
Several other equities research analysts have also recently weighed in on the stock. Bank of America cut shares of Teleflex from a “neutral” rating to an “underperform” rating and reduced their target price for the company from $235.00 to $140.00 in a research note on Tuesday, March 4th. Truist Financial cut their price target on shares of Teleflex from $140.00 to $137.00 and set a “hold” rating for the company in a research note on Monday, May 5th. Royal Bank Of Canada cut their price target on shares of Teleflex from $150.00 to $145.00 and set a “sector perform” rating for the company in a research note on Friday, May 2nd. Wall Street Zen upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Saturday, June 21st. Finally, Mizuho set a $155.00 price target on shares of Teleflex in a research note on Wednesday, April 16th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Teleflex currently has an average rating of “Hold” and a consensus price target of $164.63.
Teleflex Stock Down 0.1%
NYSE TFX opened at $119.42 on Friday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.32 and a current ratio of 2.28. The firm has a 50-day simple moving average of $124.41 and a 200 day simple moving average of $147.58. Teleflex has a twelve month low of $115.94 and a twelve month high of $249.91. The stock has a market cap of $5.28 billion, a PE ratio of 37.67, a PEG ratio of 1.87 and a beta of 1.10.
Teleflex (NYSE:TFX – Get Free Report) last released its earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, beating the consensus estimate of $2.88 by $0.03. Teleflex had a net margin of 4.96% and a return on equity of 14.73%. The business had revenue of $700.67 million during the quarter, compared to analysts’ expectations of $699.37 million. During the same quarter last year, the company earned $3.21 earnings per share. The firm’s revenue was down 5.0% on a year-over-year basis.
Institutional Trading of Teleflex
Several hedge funds have recently modified their holdings of TFX. Sanctuary Advisors LLC increased its holdings in shares of Teleflex by 28.2% during the fourth quarter. Sanctuary Advisors LLC now owns 6,251 shares of the medical technology company’s stock worth $1,143,000 after buying an additional 1,374 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund increased its holdings in shares of Teleflex by 43.0% during the fourth quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 11,644 shares of the medical technology company’s stock worth $2,072,000 after buying an additional 3,500 shares in the last quarter. IFP Advisors Inc increased its holdings in shares of Teleflex by 238.5% during the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock worth $55,000 after buying an additional 217 shares in the last quarter. Bryn Mawr Capital Management LLC acquired a new stake in shares of Teleflex during the fourth quarter worth approximately $213,000. Finally, Proficio Capital Partners LLC acquired a new stake in shares of Teleflex during the fourth quarter worth approximately $3,297,000. Institutional investors and hedge funds own 95.62% of the company’s stock.
Teleflex Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.14%. The ex-dividend date was Tuesday, May 20th. Teleflex’s payout ratio is 42.90%.
About Teleflex
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Featured Stories
- Five stocks we like better than Teleflex
- Retail Stocks Investing, Explained
- Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making?
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Value Alert: 3 High-Yield Stocks Trading at 52-Week Lows
- Business Services Stocks Investing
- Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher?
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.